Pub. Date : 2020 May
PMID : 31747091
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | EGFR inhibitors including both monoclonal antibodies (cetuximab and panitumumab) and tyrosine kinase inhibitors (erlotinib, gefitinib and dasatinib) have been used in clinical trials for the treatment of advanced cSCC, achieving only partial clinical benefit. | erlotinib | epidermal growth factor receptor | Homo sapiens |